clofilium and k201 compound

clofilium has been researched along with k201 compound in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hasumi, H; Hata, Y; Kaneko, N; Matsuda, R; Shimamoto, K	1

Other Studies

1 other study(ies) available for clofilium and k201 compound

Article	Year
K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization. European journal of pharmacology, 2007, Jan-19, Volume: 555, Issue:1 Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Electrocardiography; Heart Rate; Long QT Syndrome; Male; Methoxamine; Potassium Channel Blockers; Quaternary Ammonium Compounds; Rabbits; Sodium Channel Blockers; Thiazepines; Torsades de Pointes	2007

Article

Year

K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.

European journal of pharmacology, 2007, Jan-19, Volume: 555, Issue:1

Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Electrocardiography; Heart Rate; Long QT Syndrome; Male; Methoxamine; Potassium Channel Blockers; Quaternary Ammonium Compounds; Rabbits; Sodium Channel Blockers; Thiazepines; Torsades de Pointes

2007